Acute Myeloid Leukemia (AML) is one of the most aggressive cancers of the blood and bone marrow characterized by the rapid growth of abnormal myeloid cells. These abnormal cells interfere with the production of healthy blood cells, leading to symptoms such as fatigue, recurrent infections, fever, easy bruising, bleeding, and weight loss. AML can occur at any age but is more commonly diagnosed in older adults.
तीव्र मायलॉइड ल्युकेमिया (AML) हा रक्त आणि अस्थिमज्जेचा एक आक्रमक कर्करोग आहे, ज्यामध्ये असामान्य मायलॉइड पेशींचे जलद संचय होते. या पेशी लाल रक्तपेशी, पांढऱ्या रक्तपेशी आणि प्लेटलेट्सच्या सामान्य निर्मितीमध्ये अडथळा निर्माण करतात. हा आजार कोणत्याही वयोगटात होऊ शकतो, परंतु प्रौढ आणि वृद्ध व्यक्तींमध्ये तो अधिक आढळतो.
Breast cancer is the most commonly diagnosed cancer among American women and accounts for roughly 32% of all new female cancer cases. In 2025, an estimated 316,950 women will be diagnosed with invasive breast cancer, alongside 59,080 cases of ductal carcinoma in situ (DCIS) and 2,800 men are expected to receive a diagnosis this year. The lifetime risk for an American woman stands at 1 in 8, making breast cancer one of the most significant public health challenges in the country.
Breast cancer is the most commonly diagnosed cancer among women in the United States and remains one of the leading causes of cancer-related deaths. It develops when abnormal cells in the breast grow uncontrollably, forming a malignant tumor and can spread to other parts of the body if left untreated.
Acute Myeloid Leukemia (AML) is most common acute leukemia in adults. It is a rapidly progressing cancer of the blood and bone marrow caused by the uncontrolled growth of immature myeloid cells (blasts). These abnormal cells crowd out healthy blood-forming cells, leading to anemia, bleeding tendencies, recurrent infections, and symptoms such as fever, fatigue, easy bruising, bone pain, and enlargement of the liver or spleen.





